"Venous pain induced by peripheral intravenous infusion of gemcitabine has remained an unresolved issue in clinical practice. This study aimed to identify differences between gemcitabine formulations as well as risk factors associated with gemcitabine-induced venous pain in patients with cancer" Kawazoe et al (2020).
Kawazoe, H., Mori, N., Ido, S., Uozumi, R., Tsuneoka, K., Takeuchi, A., Matsuo, M., Yamauchi, M., Nakai, M., Sumikawa, S., Nakamura, T. and Yakushijin, Y. (2020) Liquid Formulation of Gemcitabine Increases Venous Pain in Patients With Cancer: A Retrospective Study. Clinical Therapeutics. March 8th. doi: 10.1016/j.clinthera.2020.02.010. .